leisure time -WSS

leisure time

author：comprehensive 2025-09-30 16:25:00 - browse：473

Susan Galbraith of AstraZeneca gestures while speaking – pharma coverage from STAT — Susan Galbraith, AstraZeneca’s head of cancer research and development, speaks at a STAT event in 2023. Marie Miller for STAT

CHICAGO — AstraZeneca’s head of cancer research and development, Susan Galbraith, is British, and prone to a particularly British style of understatement. She doesn’t boast loudly. But she did come to this year’s annual meeting of the American Society of Clinical Oncology wearing a small lapel pin with the numeral 6 and the “AZ” corporate logo.

That pin represents the number of years in a row that the London-based drug giant has had a presentation in the ASCO plenary, the conference’s biggest showcase for new data. This year, the company has two.

Scientific credibility is great, of course. But AstraZeneca’s shareholders want something else: return on investment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Mindstrong's demise and the future of mental health care

WSS

FDA advisers vote against ALS treatment from BrainStorm

How the Dana

Congressmen charge Covid hearing ‘could have been an email’

Cognito secures funding to test medical device for Alzheimer's

Woodcock on FDA’s accelerated approval and her next chapter

Vertex non

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

How to save PrEP access — and even expand it

FDA advisers vote against ALS treatment from BrainStorm

After affirmative action ruling, medical educators look to 'holistic review'

WHO recommends dropping component of many flu vaccines

Medical leaders decry Supreme Court decision on affirmative action

Why do women spend more than men on medical expenses?

In Memoriam: Notable people who died in 2023

Woodcock on FDA’s accelerated approval and her next chapter

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Apple Vision Pro: A first look at health apps on the new VR headset

entertainment

Vertigo drug brings hope for rare neuron disorder, Niemann

Medicare drug price negotiation program allowed for now

Did you have Obamacare on your GOP debate bingo card?

Health tech startups drop sharply from 2021 highs

Commercial surrogacy can be ethical, despite pope’s claims

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

entertainment

focus

entertainment

Wikipedia